---
$id: https://graph.org.ai/products/commodity/51161527
$type: Product
source: UNSPSC
code: "51161527"
title: "Ablukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ablukast

**UNSPSC Code**: 51161527
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C28H34O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 000TKM5BBQ, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (+-)- but generally known as ablukast, which bears US NIH Compound Identifier 57109. Ablukast most often appears in sodium form. European Medicines Agency schedules Ablukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07363MIG. The term ABLUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). ABLUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ablukast under HS 29329985 and SITC 51569. As of Q4 2014, ABLUKAST remains the US FDA Preferred Term for this commodity. Ablukast bears US NLM identifiers UMLS ID C0073512 and NCI Concept Code C74132. SMILES: O1C(CCC2C1CC(OCCCCCOC1C(CCC)C(O)C(CC1)C(=O)C)C(C2)C(=O)C)C(=O)O.

